CTOs on the Move

iSpecimen

www.ispecimen.com

 
Headquartered in Lexington, MA, iSpecimen offers an online marketplace for the purchase of human biospecimens, providing researchers with the specimens they need from the patients they want. The iSpecimen Marketplace connects healthcare organizations that have access to patients and specimens with the scientists who need them for their research and development projects. Proprietary, cloud-based technology enables researchers to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. Researchers easily and compliantly gain access to specimens to drive scientific discovery. Partner sites gain an opportunity to contribute to biomedical ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Benjamin Bielak
 Chief Information Officer Profile

Similar Companies

Viaflo

Viaflo is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Medtech Surgical Inc

Medtech Surgical Inc is a Newark, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MEDICAL EQUIPMENT RESOURCES

MEDICAL EQUIPMENT RESOURCES is a Woodlyn, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ENPRO

ENPRO is a Addison, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Elucid

Elucid is a Boston-based medical technology company using uniquely interpretable and validated AI to provide physicians with a cost-effective means to optimize treatment decisions for patients with cardiovascular disease. Advanced clinical insight from Elucid equips physicians with critical information designed to enable precision medicine. Elucid is the first FDA-Cleared and CE-marked non-invasive software to quantify atherosclerotic plaque characteristics compared to histopathology, including Lipid Rich Necrotic Core. The company has published studies for its derivation of fractional flow reserve (FFRct) based on the vasodilative capacity of the vessel wall and estimation of coding and non-coding RNA transcripts (“Virtual Transcriptomics”). This unique information informs improved treatment decisions by physicians leading to better patient outcomes, improved quality of care, and reduced healthcare costs. The Elucid software is available for commercial use in the U.S. and Europe